308 related articles for article (PubMed ID: 19166511)
1. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.
Marongiu R; Spencer B; Crews L; Adame A; Patrick C; Trejo M; Dallapiccola B; Valente EM; Masliah E
J Neurochem; 2009 Mar; 108(6):1561-74. PubMed ID: 19166511
[TBL] [Abstract][Full Text] [Related]
2. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
[TBL] [Abstract][Full Text] [Related]
3. Alterations in α-synuclein and PINK1 expression reduce neurite length and induce mitochondrial fission and Golgi fragmentation in midbrain neurons.
Furlong RM; O'Keeffe GW; O'Neill C; Sullivan AM
Neurosci Lett; 2020 Feb; 720():134777. PubMed ID: 31978495
[TBL] [Abstract][Full Text] [Related]
4. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
[TBL] [Abstract][Full Text] [Related]
5. alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells.
Hettiarachchi NT; Parker A; Dallas ML; Pennington K; Hung CC; Pearson HA; Boyle JP; Robinson P; Peers C
J Neurochem; 2009 Dec; 111(5):1192-201. PubMed ID: 19860837
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.
Martin LJ; Pan Y; Price AC; Sterling W; Copeland NG; Jenkins NA; Price DL; Lee MK
J Neurosci; 2006 Jan; 26(1):41-50. PubMed ID: 16399671
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1.
Gui YX; Wang XY; Kang WY; Zhang YJ; Zhang Y; Zhou Y; Quinn TJ; Liu J; Chen SD
Neurobiol Aging; 2012 Dec; 33(12):2841-54. PubMed ID: 22445325
[TBL] [Abstract][Full Text] [Related]
8. Function of α-synuclein and PINK1 in Lewy body dementia (Review).
Minami A; Nakanishi A; Matsuda S; Kitagishi Y; Ogura Y
Int J Mol Med; 2015 Jan; 35(1):3-9. PubMed ID: 25355138
[TBL] [Abstract][Full Text] [Related]
9. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
Gispert S; Ricciardi F; Kurz A; Azizov M; Hoepken HH; Becker D; Voos W; Leuner K; Müller WE; Kudin AP; Kunz WS; Zimmermann A; Roeper J; Wenzel D; Jendrach M; García-Arencíbia M; Fernández-Ruiz J; Huber L; Rohrer H; Barrera M; Reichert AS; Rüb U; Chen A; Nussbaum RL; Auburger G
PLoS One; 2009 Jun; 4(6):e5777. PubMed ID: 19492057
[TBL] [Abstract][Full Text] [Related]
10. Prodromal sensory neuropathy in Pink1
Valek L; Tran B; Wilken-Schmitz A; Trautmann S; Heidler J; Schmid T; Brüne B; Thomas D; Deller T; Geisslinger G; Auburger G; Tegeder I
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1060-1079. PubMed ID: 33974284
[TBL] [Abstract][Full Text] [Related]
11. P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells.
Wilkaniec A; Cieślik M; Murawska E; Babiec L; Gąssowska-Dobrowolska M; Pałasz E; Jęśko H; Adamczyk A
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486485
[TBL] [Abstract][Full Text] [Related]
12. PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy.
Nguyen TT; Kim YJ; Lai TT; Nguyen PT; Koh YH; Nguyen LTN; Ma HI; Kim YE
J Parkinsons Dis; 2022; 12(4):1201-1217. PubMed ID: 35253778
[TBL] [Abstract][Full Text] [Related]
13. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
[TBL] [Abstract][Full Text] [Related]
14. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
[TBL] [Abstract][Full Text] [Related]
15. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein.
Vicario M; Cieri D; Vallese F; Catoni C; Barazzuol L; Berto P; Grinzato A; Barbieri L; Brini M; Calì T
Cell Death Dis; 2019 Nov; 10(11):857. PubMed ID: 31719530
[TBL] [Abstract][Full Text] [Related]
16. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
17. Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein.
Ryan T; Bamm VV; Stykel MG; Coackley CL; Humphries KM; Jamieson-Williams R; Ambasudhan R; Mosser DD; Lipton SA; Harauz G; Ryan SD
Nat Commun; 2018 Feb; 9(1):817. PubMed ID: 29483518
[TBL] [Abstract][Full Text] [Related]
18. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
19. Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy.
Liu J; Wang X; Lu Y; Duan C; Gao G; Lu L; Yang H
Cell Death Dis; 2017 Sep; 8(9):e3056. PubMed ID: 28933786
[TBL] [Abstract][Full Text] [Related]
20. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.
Emmanouilidou E; Melachroinou K; Roumeliotis T; Garbis SD; Ntzouni M; Margaritis LH; Stefanis L; Vekrellis K
J Neurosci; 2010 May; 30(20):6838-51. PubMed ID: 20484626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
